Further studies explored the relationship between CDK4 expression and clinicopathological characteristics using a TMA containing 50 synovial sarcoma cases with clinical information, and a TMA containing 59 various sarcoma cases with up to 112 months of follow-up data. Here, CDK4 is linked to sarcoma.